Adipocyte EET-PGC1alpha-HO-1 in Obesity-driven Hypertension
肥胖引起的高血压中的脂肪细胞 EET-PGC1α-HO-1
基本信息
- 批准号:9769285
- 负责人:
- 金额:$ 50.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdipocytesAdverse effectsAnimal ModelAnimalsAntihypertensive AgentsAntioxidantsAttenuatedBiogenesisBlood PressureBlood VesselsBody Weight decreasedBone MarrowCardiovascular DiseasesCardiovascular systemCytochrome P450DataDevelopmentDiabetes MellitusDietDiseaseEatingEnergy MetabolismEpidemicExhibitsEyeFatty acid glycerol estersFundingFutureGene ExpressionGenesGoalsHealthHigh Fat DietHyperglycemiaHypertensionImpairmentInflammationInflammatoryInsulin ReceptorInsulin ResistanceKnockout MiceKnowledgeLeadLife StyleMediatingMedicalMetabolicMetabolic DiseasesMetabolic syndromeMethodsMitochondriaMitogen-Activated Protein KinasesModernizationMusNamesObesityOxidative StressOxygen ConsumptionPathogenesisPathway interactionsPeripheralPharmaceutical PreparationsPhenotypePhosphorylationProductionRegulatory PathwayRisk FactorsRodentSignal PathwaySignal TransductionSignaling MoleculeSolidStem cellsStrokeSystemTestingTissuesVascular DiseasesVasodilator AgentsWeight GainWorkadipocyte differentiationadiponectinattenuationcytokinedesignexperimental studyfeedingglucose uptakehealth managementheme oxygenase-1indexinginflammatory markerinsulin sensitivitylipid biosynthesismetabolic phenotypenew therapeutic targetnovelnovel therapeuticsobesity developmentoverexpressionpreventresponsetranscription factor
项目摘要
SUMMARY
Obesity is a “silent” epidemic disease and a risk factor for development of cardiovascular disease including
hypertension. Although obesity/metabolic syndrome is theoretically treatable with modern medical, lifestyle and
eating management methods, this is not a trivial undertaking and our national battle with this “silent disease” is
not going well. However, identifying novel pathways that mitigate the deleterious effects of oxidative stress and
inflammation in obesity can lead to better future treatment options and health management. We have
successfully implicated heme oxygenase-1 (HO-1) and cytochrome P450-epoxygenase-derived EETs in the
implementation of anti-hypertensive and anti-adipogenic mechanisms that enhances insulin sensitivity, weight
loss and energy expenditure. In obesity and diabetes, HO-1 expression is repressed and EETs in fat tissues
are decreased. Relevant to this application we found that selective adipocyte HO-1 overexpression attenuated
obesity-induced hypertension, while adipocyte-selective HO-1 deletion in null mice exhibit diminished levels of
EETs and PGC1α, a transcription factor known to regulate mitochondrial biogenesis and peripheral insulin
sensitivity. Preliminary results also revealed that amplification of the HO-1-EET circuit activates PGC-1α.
Collectively, the aforementioned observations support the hypothesis that HO-1 of adipocytes is a
positive regulator of adipocyte EET production and adiponectin, leading to activation of a signaling
pathway involving PGC1α which controls mitochondrial function(s), decreases formation of ROS, and
increases insulin sensitivity, all of which may contribute to set the levels of blood pressure. A corollary
of this is that a deficit in the functionality of this adipocyte pathway (e.g., impaired HO-1 expression,
EET synthesis, and/or PGC1α level), as appears to occur in adipocytes of animal models of obesity-
induced hypertension and related conditions may be a contributor to the pathogenesis of such disease
states. The proposed experimentation is designed to explore these concepts in relation to the involvement of a
deficit in adipocytes of the HO-1-EET-PGC1α system in the pathogenesis of obesity and hypertension in fat
fed mice. We will manipulate the expression of HO-1, CYP2C44(EETs) and PGC1α genes within adipocytes
and assess the effect on metabolic and cardiovascular parameters including insulin sensitivity, oxygen
consumption, weight gain, vascular function and blood pressure as well as on adipogenic markers and
signaling molecules that are indices of adipocyte phenotype in health and disease. We will further focus on the
key signaling components of the PGC1α pathway including MAP kinases, and insulin receptor phosphorylation
in adipocyte stem cells and the reliance of PGC1α actions on active adipocyte HO-1 and CYP2C44-EETs
during adipogenesis. The experiments outlined in this proposal will provide us with a solid working knowledge
of how HO-1-EET interact with key signaling pathways to regulate insulin sensitivity and hypertension with an
eye on the identification of new therapeutic targets for attenuation of obesity and metabolic disease.
概括
肥胖是一种“无声”的流行病,也是心血管疾病发展的危险因素,包括
高血压。尽管肥胖/代谢综合征理论上可以通过现代医学、生活方式和生活方式来治疗
饮食管理方法,这不是一件小事,我们全国与这种“沉默的疾病”的战斗
进展不顺利。然而,确定减轻氧化应激有害影响的新途径
肥胖引起的炎症可以带来更好的未来治疗选择和健康管理。我们有
成功地将血红素加氧酶-1 (HO-1) 和细胞色素 P450 环氧合酶衍生的 EET 与
实施抗高血压和抗脂肪形成机制,增强胰岛素敏感性、体重
损失和能量消耗。在肥胖和糖尿病中,脂肪组织中的 HO-1 表达和 EET 受到抑制
减少。与此应用相关,我们发现选择性脂肪细胞 HO-1 过表达减弱
肥胖诱发的高血压,而无效小鼠中脂肪细胞选择性 HO-1 缺失则表现出脂肪细胞水平降低
EET 和 PGC1α(一种已知调节线粒体生物发生和外周胰岛素的转录因子)
敏感性。初步结果还表明,HO-1-EET 电路的放大会激活 PGC-1α。
总的来说,上述观察结果支持脂肪细胞的 HO-1 是一种脂肪细胞的假设。
脂肪细胞 EET 产生和脂联素的正调节因子,导致信号传导的激活
涉及 PGC1α 的通路控制线粒体功能,减少 ROS 的形成,以及
增加胰岛素敏感性,所有这些都可能有助于设定血压水平。推论
其中之一是该脂肪细胞途径的功能缺陷(例如,HO-1 表达受损,
EET 合成和/或 PGC1α 水平),似乎发生在肥胖动物模型的脂肪细胞中 -
诱发的高血压和相关病症可能是此类疾病的发病机制的一个因素
州。拟议的实验旨在探索与参与相关的这些概念
脂肪细胞 HO-1-EET-PGC1α 系统缺陷在肥胖和高血压发病机制中的作用
喂老鼠。我们将操纵脂肪细胞内 HO-1、CYP2C44(EETs) 和 PGC1α 基因的表达
并评估对代谢和心血管参数的影响,包括胰岛素敏感性、氧气
消耗、体重增加、血管功能和血压以及脂肪生成标记物和
信号分子是健康和疾病中脂肪细胞表型的指标。我们将进一步关注
PGC1α 通路的关键信号传导成分,包括 MAP 激酶和胰岛素受体磷酸化
脂肪细胞干细胞中的 PGC1α 作用对活性脂肪细胞 HO-1 和 CYP2C44-EET 的依赖
在脂肪生成过程中。本提案中概述的实验将为我们提供扎实的工作知识
HO-1-EET 如何与关键信号通路相互作用以调节胰岛素敏感性和高血压
着眼于确定减轻肥胖和代谢疾病的新治疗靶点。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sirt6 Deacetylase: A Potential Key Regulator in the Prevention of Obesity, Diabetes and Neurodegenerative Disease.
- DOI:10.3389/fphar.2020.598326
- 发表时间:2020
- 期刊:
- 影响因子:5.6
- 作者:Raj S;Dsouza LA;Singh SP;Kanwal A
- 通讯作者:Kanwal A
The Peroxisome Proliferator-Activated Receptor-Gamma Coactivator-1α-Heme Oxygenase 1 Axis, a Powerful Antioxidative Pathway with Potential to Attenuate Diabetic Cardiomyopathy.
过氧化物酶体增殖物激活受体-γ 辅激活剂-1α-血红素加氧酶 1 轴,一种强大的抗氧化途径,具有减轻糖尿病心肌病的潜力。
- DOI:10.1089/ars.2019.7989
- 发表时间:2020
- 期刊:
- 影响因子:6.6
- 作者:Waldman,Maayan;Arad,Michael;Abraham,NaderG;Hochhauser,Edith
- 通讯作者:Hochhauser,Edith
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nader G. Abraham其他文献
Significance of heme oxygenase in cardiovascular diseases
- DOI:
10.1016/j.biopha.2008.07.038 - 发表时间:
2008-10-01 - 期刊:
- 影响因子:
- 作者:
Nader G. Abraham - 通讯作者:
Nader G. Abraham
RETRACTED ARTICLE: The Na/K-ATPase Oxidant Amplification Loop Regulates Aging
撤回文章:钠钾-ATP 酶氧化剂放大环调节衰老
- DOI:
10.1038/s41598-018-26768-9 - 发表时间:
2018-06-26 - 期刊:
- 影响因子:3.900
- 作者:
Komal Sodhi;Alexandra Nichols;Amrita Mallick;Rebecca L. Klug;Jiang Liu;Xiaoliang Wang;Krithika Srikanthan;Perrine Goguet-Rubio;Athar Nawab;Rebecca Pratt;Megan N. Lilly;Juan R. Sanabria;Zijian Xie;Nader G. Abraham;Joseph I. Shapiro - 通讯作者:
Joseph I. Shapiro
Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.
血红素可抑制人类免疫缺陷病毒 1 在细胞培养物中的复制,并增强齐多夫定的抗病毒作用。
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:11.1
- 作者:
R. Levere;Yi;A. Kappas;Doris Bucher;Gary P. Wormser;Nader G. Abraham - 通讯作者:
Nader G. Abraham
Mechanisms of Physical and Emotional Stress
身体和情绪压力的机制
- DOI:
10.1007/978-1-4899-2064-5 - 发表时间:
1988 - 期刊:
- 影响因子:0.9
- 作者:
Irun R. Cohen;Mehdi Tavassoli;E. Zanjani;Joao L. Ascensao;Nader G. Abraham;Lynn Loriaux;G. Chrousos;P. Gold - 通讯作者:
P. Gold
HO-1 pharmacological over-expression in a rat model of Type II diabetes: implications for microvascular tone and the genesis of ischemia
- DOI:
10.1016/j.biopha.2008.07.044 - 发表时间:
2008-10-01 - 期刊:
- 影响因子:
- 作者:
Cecilia Vecoli;Danilo Neglia;Daniela Giannessi;Maristella Maltinti;Michela Novelli;Pellegrino Masiello;Nader G. Abraham;Nazareno Paolocci;L'Abbate Antonio - 通讯作者:
L'Abbate Antonio
Nader G. Abraham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nader G. Abraham', 18)}}的其他基金
Oxidative Stress and Vascular HO in Diabetes
糖尿病中的氧化应激和血管 H2O2
- 批准号:
8031600 - 财政年份:2010
- 资助金额:
$ 50.29万 - 项目类别:
Oxidative Stress and Vascular HO in Diabetes
糖尿病中的氧化应激和血管 H2O2
- 批准号:
7145623 - 财政年份:2006
- 资助金额:
$ 50.29万 - 项目类别:
Oxidative Stress and Vascular HO in Diabetes
糖尿病中的氧化应激和血管 H2O2
- 批准号:
7630645 - 财政年份:2006
- 资助金额:
$ 50.29万 - 项目类别:
Oxidative Stress and Vascular HO in Diabetes
糖尿病中的氧化应激和血管 H2O2
- 批准号:
7893856 - 财政年份:2006
- 资助金额:
$ 50.29万 - 项目类别:
Oxidative Stress and Vascular HO in Diabetes
糖尿病中的氧化应激和血管 H2O2
- 批准号:
8011295 - 财政年份:2006
- 资助金额:
$ 50.29万 - 项目类别:
Oxidative Stress and Vascular HO in Diabetes
糖尿病中的氧化应激和血管 H2O2
- 批准号:
7440201 - 财政年份:2006
- 资助金额:
$ 50.29万 - 项目类别:
Oxidative Stress and Vascular HO in Diabetes
糖尿病中的氧化应激和血管 H2O2
- 批准号:
7276681 - 财政年份:2006
- 资助金额:
$ 50.29万 - 项目类别:
Oxidative Stress and Vascular HO in Diabetes
糖尿病中的氧化应激和血管 H2O2
- 批准号:
7632248 - 财政年份:2006
- 资助金额:
$ 50.29万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
- 批准号:
23K16058 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
- 批准号:
23K10969 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
- 批准号:
23H03065 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
- 批准号:
23K05107 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
- 批准号:
23K19518 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
- 批准号:
23K18303 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
- 批准号:
10655793 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
- 批准号:
23K05594 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
- 批准号:
10334113 - 财政年份:2022
- 资助金额:
$ 50.29万 - 项目类别: